BFO
CYT

Boston Family Office’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Boston Family Office’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,197
Closed -$73K – 278
2024
Q1 		$73K Hold
24,197
– – 0.01% 262
2023
Q4 		$74K Hold
24,197
– – 0.01% 258
2023
Q3 		$69K Hold
24,197
– – 0.01% 252
2023
Q2 		$62K Buy
+24,197
New +$62K ﹤0.01% 259